0.4782
price down icon1.73%   -0.0084
 
loading

Turnstone Biologics Corp Stock (TSBX) Financials Data

Income Statement
Quarterly
*All numbers in millions
Period End Date 2024-03-31 2023-12-31 2023-09-30 2023-03-30
Period Length 3 Months 3 Months 3 Months 3 Months
Revenues
-
- - 19.31
Operating Expenses
15.88%
20.69
17.86 18.93 19.70
Operating Income/Loss
15.88%
-20.69
-17.86 -18.93 -0.394
Nonoperating Income/Loss
13.13%
1.078
1.241 1.578 0.38
Income/Loss From Continuing Operations Before Tax
18.04%
-19.61
-16.61 -17.35 0.068
Income Tax Expense/Benefit
109.70%
0.016
-0.165 -0.033 -0.082
Income/Loss From Continuing Operations After Tax
19.33%
-19.63
-16.45 -17.32 0.068
Net Income/Loss
19.33%
-19.63
-16.45 -17.32 0.068
Preferred Stock Dividends And Other Adjustments
-
- - -
Attributable To Noncontrolling Interest
-
- - -
Basic Average Shares
500.48%
23.01
3.8322 17.40 -12.51
Diluted Average Shares
500.48%
23.01
3.8322 17.40 -12.51
Basic Earnings Per Share
454.17%
-0.85
0.24 -1.00 3.54
Diluted Earnings Per Share
454.17%
-0.85
0.24 -1.00 3.54
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - -
$80.78
price down icon 0.82%
$20.67
price down icon 0.53%
$353.75
price down icon 0.12%
$5.04
price down icon 2.14%
biotechnology ONC
$228.87
price up icon 0.53%
$119.94
price down icon 1.99%
Cap:     |  Volume (24h):